Cetera Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
MMEA
Cetera Advisors's ARKG Position: Q1 2024 in Review
Cetera Advisors increased its ARK Genomic Revolution ETF (ARKG) stake by 2.2% in Q1 2024, buying an estimated $42.3K and bringing the position to 65,670 shares worth $1.89M. The position accounts for 0.01% of the portfolio, ranked #843.
Cetera Advisors first reported a position in ARKG in Q1 2019 and has held it in 17 quarters since. The position peaked at $5.45M in Q3 2021. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.
- Cetera Advisors held 65,670 shares of ARK Genomic Revolution ETF worth $1.89M as of Q1 2024.
- Cetera Advisors bought 1,407 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $42.3K.
- ARK Genomic Revolution ETF made up 0.01% of Cetera Advisors's portfolio in Q1 2024, its #843 holding.
- Cetera Advisors first reported a position in ARK Genomic Revolution ETF in Q1 2019 and has held it in 17 quarters since.
- Cetera Advisors's ARK Genomic Revolution ETF position peaked at $5.45M in Q3 2021.
- 284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.
Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.